Oct-1 Antibody 4428S from Cell Signaling Technology

Product Specs
ItemOct-1 Antibody
CompanyCell Signaling Technology
Price $306.00 Inquire
Catalog Number4428S
Quantity100 µl
ApplicationsW
ReactivityH
TargetOct-1
HostRabbit
NCBI Gene AliasesOCT1, OTF1, Oct1Z, oct-1B
NCBI Full Gene NamePOU class 2 homeobox 1
ClonalityPolyclonal
Research AreaDevelopmental Biology
Molecular Weight90

Add to Compare List

Cell Signaling Technology

3 Trask Lane

Danvers, Massachusetts 01923

United States

Phone: 877-616-CELL
Phone: 978-867-2388
Fax: 866-432-6112
Fax: 978-867-2488

Company Profile

Website: http://www.cellsignal.com/

Website: Technical Support

(1) Mitochondrial transfer to granulocytic myeloid-derived suppressor cells augments immunosuppressive activityCell ReportsMarch 24, 2026Prabhakar Arumugam, Cortney E. Heim, Rachel W. Fallet, Dhananjay D. Shinde, Vinai C. Thomas, Rafael J. Argüello, Tammy Kielian,Cayman Chemical,11046 Mitotracker Green FM,Cell Signaling Technology,9074S MitoSOX,Invitrogen,M36008 MitoPY1,Tocris,4428 MitoTracker Deep Red FM,Cell Signaling Technology,8778S CellTracker Violet BMQC,Invitrogen,C10094 Rhodamine Phalloidin

(2) A positive feedback loop between FOSB and miR-133b controls colon cancer cell proliferationActa Biochimica et Biophysica SinicaMarch 28, 2025Wanwan Li, Qionggui Hu, Changwei Lin, Xiaorong Li, Yang Bai, Min Mawere against the following molecules: FOSB (#2251; Cell Signaling Technology, Danvers, USA), POU2F1 (#4428; Cell Signaling Technology), BCL-2 (HGNC: 990, #3498; Cell Signaling Technology), Cyclin D1 (HGNC: 1582

(3) Trichosanthin enhances the antitumor effect of gemcitabine in non‑small cell lung cancer via inhibition of the PI3K/AKT pathwayExperimental and Therapeutic MedicineOctober 11, 2017Naren Tuya, Yadi Wang, Lanmei Tong, Weishi Gao, Rong Yu, Liying Xueincubated with primary antibodies against phosphorylated (p)‑phosphoinositide 3‑kinase (PI3K) p85 (#4428), p‑AKT (#4060), p‑ERK (#4370), ERK (#4695) and GAPDH (#3683) for 2 h at room temperature. The primary antibodies

(4) Identification of a nucleoside analog active against adenosine kinase-expressing plasma cell malignanciesThe Journal of clinical investigationJune 1, 2017Nayar U, Sadek J, Reichel J, Hernandez-Hopkins D, Akar G, Barelli PJ, Sahai MA, Zhou H, Totonchy J, Jayabalan D, et al.Signaling Technology, C22B4), p50 (Cell Signaling Technology, 3035), Oct-1 (Cell Signaling Technology, 4428), pIκBα (Santa Cruz Biotechnology, B-9 sc-8404), IκBα (Santa Cruz Biotechnology, C-21 sc-371), pIKKα/β

(5) Androgen receptor transcriptionally regulates semaphorin 3C in a GATA2-dependent mannerOncotargetFebruary 7, 2017Tam KJ, Dalal K, Hsing M, Cheng CW, Khosravi S, Yenki P, Tse C, Peacock JW, Sharma A, Chiang YT, et al.sc-6553), POU2F1 (Santa Cruz Biotechnology, Cat. No.s sc-232, sc-8024; Cell Signaling Technology, Cat. No. 4428S), actin (Sigma-Aldrich, Cat. No. A2066), and vinculin (Sigma-Aldrich, Cat. No. V4505). Secondary antibodies:

(6) Non-tuberculous Mycobacteria in South African Wildlife: Neglected Pathogens and Potential Impediments for Bovine Tuberculosis DiagnosisFrontiers in Cellular and Infection MicrobiologyJanuary 30, 2017Nomakorinte Gcebe, Tiny M. Hlokwepalustre, M. avium subsp. avium, M. virginiense, M. sherrisiii, M. vulneris, M. hecheshornense DSM 4428/M. sydneyiensis/M. xenopi “Hyn” Wue-TB939/99, M. parafortuitum, M. sp. NJB901/M.sp. B6. 10-23/M. sp.

(7) Leishmania donovani-Induced Increase in Macrophage Bcl-2 Favors Parasite SurvivalFrontiers in immunologyJanuary 1, 2016Pandey RK, Mehrotra S, Sharma S, Gudde RS, Sundar S, Shaha C.(Cell Signaling Technologies, Cat. No. D3A7), p-PI3K (1:1000) (Cell Signaling Technologies, Cat. No. 4428), p-Akt (1:1000) (Cell Signaling Technologies, Cat. No. 9271), iNOS (1:1000) (Santa Cruz Biotechnology,

Be the First to Write a Review!

Oct-1 Antibody

Oct-1 Antibody from Cell Signaling Technology

Description

Cell Signaling Technology

Citations (7)

Reviews

Oct-1 Antibody from Cell Signaling Technology

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map